PrismRA accurately predicted which patients with rheumatoid arthritis would not achieve EULAR good response criteria at six months of treatment using either adalimumab or etanercept.
Read More
Standard Molecular launched cloud-based ConnectOTR to clear the administrative burden limiting community oncologists from accessing molecular testing for patients.
Read More
“The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” says first author Susan Domchek, MD.
Read More
Research published in the Journal of General Virology has identified missed cases of SARS-CoV-2 by retrospective testing of throat swabs.
Read More
The Centers for Medicare & Medicaid Services has granted Advanced Diagnostic Laboratory Test status for the Signatera molecular residual disease test.
Read More